Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000235778 refers to a ubiquitin-specific protease pseudogene, also known as the ubiquitin carboxyl-terminal hydrolase 17-like pseudogene (LOC402329)[3]. Pseudogenes are genomic sequences related to protein-coding genes but are non-functional due to mutations or genetic rearrangements. Unlike their functional protein-coding relatives—such as the ubiquitin-specific protease (USP) family, which are involved in protein regulation via the ubiquitin-proteasome system and play key roles in processes like cell cycle regulation, apoptosis, and cancer—this pseudogene does not produce an active enzyme and does not participate in these pathways[3][2]. There are no known roles for this pseudogene in disease, no interacting drugs, and no mechanism of action or safety concerns associated with it. Its primary distinction is that, while it shares sequence similarity with functional USP genes, it remains non-functional and is not considered a therapeutic target.
None (not druggable, no mechanism of action)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin-specific protease pseudogene.